CHE vs MA · P/E 24, rev $2.43B vs P/E 38, rev $32.79B
Chemed Corp (CHE) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the CHE and MA stock pages for the full models.
Not investment advice.